Oral Contrast Agent-North America Market Status and Trend Report 2013-2023
Report Summary
Oral Contrast Agent-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Contrast Agent industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Oral Contrast Agent 2013-2017, and development forecast 2018-2023
Main market players of Oral Contrast Agent in North America, with company and product introduction, position in the Oral Contrast Agent market
Market status and development trend of Oral Contrast Agent by types and applications
Cost and profit status of Oral Contrast Agent, and marketing status
Market growth drivers and challenges
The report segments the North America Oral Contrast Agent market as:
North America Oral Contrast Agent Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Oral Contrast Agent Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
North America Oral Contrast Agent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
North America Oral Contrast Agent Market: Players Segment Analysis (Company and Product introduction, Oral Contrast Agent Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oral Contrast Agent-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Contrast Agent industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Oral Contrast Agent 2013-2017, and development forecast 2018-2023
Main market players of Oral Contrast Agent in North America, with company and product introduction, position in the Oral Contrast Agent market
Market status and development trend of Oral Contrast Agent by types and applications
Cost and profit status of Oral Contrast Agent, and marketing status
Market growth drivers and challenges
The report segments the North America Oral Contrast Agent market as:
North America Oral Contrast Agent Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Oral Contrast Agent Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
North America Oral Contrast Agent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
North America Oral Contrast Agent Market: Players Segment Analysis (Company and Product introduction, Oral Contrast Agent Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ORAL CONTRAST AGENT
1.1 Definition of Oral Contrast Agent in This Report
1.2 Commercial Types of Oral Contrast Agent
1.2.1 Barium-based Contrast Media
1.2.2 Iodinated Contrast Media
1.2.3 Gadolinium-based Contrast Media
1.2.4 Microbubble Contrast Media
1.3 Downstream Application of Oral Contrast Agent
1.3.1 Cardiovascular Disorders
1.3.2 Cancer
1.3.3 Gastrointestinal Disorders
1.3.4 Musculoskeletal Disorders
1.3.5 Neurological Disorders
1.3.6 Nephrological Disorders
1.4 Development History of Oral Contrast Agent
1.5 Market Status and Trend of Oral Contrast Agent 2013-2023
1.5.1 North America Oral Contrast Agent Market Status and Trend 2013-2023
1.5.2 Regional Oral Contrast Agent Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oral Contrast Agent in North America 2013-2017
2.2 Consumption Market of Oral Contrast Agent in North America by Regions
2.2.1 Consumption Volume of Oral Contrast Agent in North America by Regions
2.2.2 Revenue of Oral Contrast Agent in North America by Regions
2.3 Market Analysis of Oral Contrast Agent in North America by Regions
2.3.1 Market Analysis of Oral Contrast Agent in United States 2013-2017
2.3.2 Market Analysis of Oral Contrast Agent in Canada 2013-2017
2.3.3 Market Analysis of Oral Contrast Agent in Mexico 2013-2017
2.4 Market Development Forecast of Oral Contrast Agent in North America 2018-2023
2.4.1 Market Development Forecast of Oral Contrast Agent in North America 2018-2023
2.4.2 Market Development Forecast of Oral Contrast Agent by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Oral Contrast Agent in North America by Types
3.1.2 Revenue of Oral Contrast Agent in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Oral Contrast Agent in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oral Contrast Agent in North America by Downstream Industry
4.2 Demand Volume of Oral Contrast Agent by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oral Contrast Agent by Downstream Industry in United States
4.2.2 Demand Volume of Oral Contrast Agent by Downstream Industry in Canada
4.2.3 Demand Volume of Oral Contrast Agent by Downstream Industry in Mexico
4.3 Market Forecast of Oral Contrast Agent in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL CONTRAST AGENT
5.1 North America Economy Situation and Trend Overview
5.2 Oral Contrast Agent Downstream Industry Situation and Trend Overview
CHAPTER 6 ORAL CONTRAST AGENT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Oral Contrast Agent in North America by Major Players
6.2 Revenue of Oral Contrast Agent in North America by Major Players
6.3 Basic Information of Oral Contrast Agent by Major Players
6.3.1 Headquarters Location and Established Time of Oral Contrast Agent Major Players
6.3.2 Employees and Revenue Level of Oral Contrast Agent Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORAL CONTRAST AGENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GE Healthcare (US)
7.1.1 Company profile
7.1.2 Representative Oral Contrast Agent Product
7.1.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of GE Healthcare (US)
7.2 Bracco Imaging (Italy)
7.2.1 Company profile
7.2.2 Representative Oral Contrast Agent Product
7.2.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Bracco Imaging (Italy)
7.3 Bayer HealthCare (Germany)
7.3.1 Company profile
7.3.2 Representative Oral Contrast Agent Product
7.3.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Bayer HealthCare (Germany)
7.4 Guerbet (France)
7.4.1 Company profile
7.4.2 Representative Oral Contrast Agent Product
7.4.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Guerbet (France)
7.5 Lantheus (US)
7.5.1 Company profile
7.5.2 Representative Oral Contrast Agent Product
7.5.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Lantheus (US)
7.6 Daiichi Sankyo (Japan)
7.6.1 Company profile
7.6.2 Representative Oral Contrast Agent Product
7.6.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Daiichi Sankyo (Japan)
7.7 Unijules Life Sciences (India)
7.7.1 Company profile
7.7.2 Representative Oral Contrast Agent Product
7.7.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Unijules Life Sciences (India)
7.8 J.B. Chemicals and Pharmaceuticals (India)
7.8.1 Company profile
7.8.2 Representative Oral Contrast Agent Product
7.8.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of J.B. Chemicals and Pharmaceuticals (India)
7.9 Spago Nanomedicine (Sweden)
7.9.1 Company profile
7.9.2 Representative Oral Contrast Agent Product
7.9.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Spago Nanomedicine (Sweden)
7.10 Taejoon Pharm (South Korea)
7.10.1 Company profile
7.10.2 Representative Oral Contrast Agent Product
7.10.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Taejoon Pharm (South Korea)
7.11 Jodas (India)
7.11.1 Company profile
7.11.2 Representative Oral Contrast Agent Product
7.11.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Jodas (India)
7.12 Magnus Health (India)
7.12.1 Company profile
7.12.2 Representative Oral Contrast Agent Product
7.12.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Magnus Health (India)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL CONTRAST AGENT
8.1 Industry Chain of Oral Contrast Agent
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL CONTRAST AGENT
9.1 Cost Structure Analysis of Oral Contrast Agent
9.2 Raw Materials Cost Analysis of Oral Contrast Agent
9.3 Labor Cost Analysis of Oral Contrast Agent
9.4 Manufacturing Expenses Analysis of Oral Contrast Agent
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL CONTRAST AGENT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Oral Contrast Agent in This Report
1.2 Commercial Types of Oral Contrast Agent
1.2.1 Barium-based Contrast Media
1.2.2 Iodinated Contrast Media
1.2.3 Gadolinium-based Contrast Media
1.2.4 Microbubble Contrast Media
1.3 Downstream Application of Oral Contrast Agent
1.3.1 Cardiovascular Disorders
1.3.2 Cancer
1.3.3 Gastrointestinal Disorders
1.3.4 Musculoskeletal Disorders
1.3.5 Neurological Disorders
1.3.6 Nephrological Disorders
1.4 Development History of Oral Contrast Agent
1.5 Market Status and Trend of Oral Contrast Agent 2013-2023
1.5.1 North America Oral Contrast Agent Market Status and Trend 2013-2023
1.5.2 Regional Oral Contrast Agent Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oral Contrast Agent in North America 2013-2017
2.2 Consumption Market of Oral Contrast Agent in North America by Regions
2.2.1 Consumption Volume of Oral Contrast Agent in North America by Regions
2.2.2 Revenue of Oral Contrast Agent in North America by Regions
2.3 Market Analysis of Oral Contrast Agent in North America by Regions
2.3.1 Market Analysis of Oral Contrast Agent in United States 2013-2017
2.3.2 Market Analysis of Oral Contrast Agent in Canada 2013-2017
2.3.3 Market Analysis of Oral Contrast Agent in Mexico 2013-2017
2.4 Market Development Forecast of Oral Contrast Agent in North America 2018-2023
2.4.1 Market Development Forecast of Oral Contrast Agent in North America 2018-2023
2.4.2 Market Development Forecast of Oral Contrast Agent by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Oral Contrast Agent in North America by Types
3.1.2 Revenue of Oral Contrast Agent in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Oral Contrast Agent in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oral Contrast Agent in North America by Downstream Industry
4.2 Demand Volume of Oral Contrast Agent by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oral Contrast Agent by Downstream Industry in United States
4.2.2 Demand Volume of Oral Contrast Agent by Downstream Industry in Canada
4.2.3 Demand Volume of Oral Contrast Agent by Downstream Industry in Mexico
4.3 Market Forecast of Oral Contrast Agent in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL CONTRAST AGENT
5.1 North America Economy Situation and Trend Overview
5.2 Oral Contrast Agent Downstream Industry Situation and Trend Overview
CHAPTER 6 ORAL CONTRAST AGENT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Oral Contrast Agent in North America by Major Players
6.2 Revenue of Oral Contrast Agent in North America by Major Players
6.3 Basic Information of Oral Contrast Agent by Major Players
6.3.1 Headquarters Location and Established Time of Oral Contrast Agent Major Players
6.3.2 Employees and Revenue Level of Oral Contrast Agent Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORAL CONTRAST AGENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GE Healthcare (US)
7.1.1 Company profile
7.1.2 Representative Oral Contrast Agent Product
7.1.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of GE Healthcare (US)
7.2 Bracco Imaging (Italy)
7.2.1 Company profile
7.2.2 Representative Oral Contrast Agent Product
7.2.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Bracco Imaging (Italy)
7.3 Bayer HealthCare (Germany)
7.3.1 Company profile
7.3.2 Representative Oral Contrast Agent Product
7.3.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Bayer HealthCare (Germany)
7.4 Guerbet (France)
7.4.1 Company profile
7.4.2 Representative Oral Contrast Agent Product
7.4.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Guerbet (France)
7.5 Lantheus (US)
7.5.1 Company profile
7.5.2 Representative Oral Contrast Agent Product
7.5.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Lantheus (US)
7.6 Daiichi Sankyo (Japan)
7.6.1 Company profile
7.6.2 Representative Oral Contrast Agent Product
7.6.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Daiichi Sankyo (Japan)
7.7 Unijules Life Sciences (India)
7.7.1 Company profile
7.7.2 Representative Oral Contrast Agent Product
7.7.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Unijules Life Sciences (India)
7.8 J.B. Chemicals and Pharmaceuticals (India)
7.8.1 Company profile
7.8.2 Representative Oral Contrast Agent Product
7.8.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of J.B. Chemicals and Pharmaceuticals (India)
7.9 Spago Nanomedicine (Sweden)
7.9.1 Company profile
7.9.2 Representative Oral Contrast Agent Product
7.9.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Spago Nanomedicine (Sweden)
7.10 Taejoon Pharm (South Korea)
7.10.1 Company profile
7.10.2 Representative Oral Contrast Agent Product
7.10.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Taejoon Pharm (South Korea)
7.11 Jodas (India)
7.11.1 Company profile
7.11.2 Representative Oral Contrast Agent Product
7.11.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Jodas (India)
7.12 Magnus Health (India)
7.12.1 Company profile
7.12.2 Representative Oral Contrast Agent Product
7.12.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Magnus Health (India)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL CONTRAST AGENT
8.1 Industry Chain of Oral Contrast Agent
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL CONTRAST AGENT
9.1 Cost Structure Analysis of Oral Contrast Agent
9.2 Raw Materials Cost Analysis of Oral Contrast Agent
9.3 Labor Cost Analysis of Oral Contrast Agent
9.4 Manufacturing Expenses Analysis of Oral Contrast Agent
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL CONTRAST AGENT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
